Nuvation Bio Inc. NUVB.WT / USD Stock

Overview Charts & Stats for the Selected Time Period

This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.

Settings

Asset NUVB.WT / USD

Latest Price 0.0051

Price Change % Calculating...

Price Change X Calculating...

Up Days Calculating...

Down Days Calculating...

Avg Up Day % Calculating...

Avg Down Day % Calculating...

Median Up Day % Calculating...

Median Down Day % Calculating...

Volatility % 19.33%

Win Rate % 46.4%

CAGR % -99.99%

Best Day % +74.13%

Worst Day % -73.38%

Max Drawdown % -99.34%

Period High 0.62

Period Low 0.00

From High % -99.2%

From Low % +24.4%

Sharpe Ratio -0.03

Days >Avg % 54.1%

Total Volume 9,007,048

Volume: 2026-02-10

Aggregate Volume: 146 Days

Price Chart Percentage Gains

The price chart compares the percentage returns for each asset in the given time period. Each starts out at 0% at the x axis left most position.

Price Overlay ChartPercentage Gains

The overlay price chart displays the price movements of each asset over the selected period, using individual y-axes for each. This allows for an easy comparison of assets with different magnitudes, making it great for identifying correlations.

Volume Chart Daily Volume

This volume chart shows the daily volume for each asset.

Learn More

This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.

What is Nuvation Bio Inc.?

This company is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for challenging diseases. It operates within the biotechnology sector, a dynamic and research-intensive industry driven by scientific advancement and the pursuit of novel treatments. The company's pipeline includes drug candidates targeting various indications, with a particular emphasis on oncology and autoimmune disorders. These potential therapies are designed to address unmet medical needs, aiming to offer improved efficacy and safety profiles compared to existing treatments. Their strategy involves leveraging cutting-edge scientific platforms to identify and advance promising drug candidates through preclinical and clinical development. The market position of this company is that of an emerging player in the biopharmaceutical landscape. Success hinges on the successful progression of its clinical trials and eventual regulatory approval of its drug candidates. The company's valuation and future prospects are intrinsically linked to the scientific validation and commercial viability of its therapeutic pipeline.

🤖 AI Analysis

Model:

Ask me anything about the data on this page. I can help explain metrics, identify patterns, or answer specific questions.

Data sources

Trade hundreds of crypto perpetual futures